GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Lotus Bio-Technology Development Corp (OTCPK:LBTD) » Definitions » Cash Conversion Cycle

Lotus Bio-Technology Development (Lotus Bio-Technology Development) Cash Conversion Cycle : 0.00 (As of Dec. 2017)


View and export this data going back to 2013. Start your Free Trial

What is Lotus Bio-Technology Development Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Lotus Bio-Technology Development's Days Sales Outstanding for the three months ended in Dec. 2017 was .
Lotus Bio-Technology Development's Days Inventory for the three months ended in Dec. 2017 was .
Lotus Bio-Technology Development's Days Payable for the three months ended in Dec. 2017 was .
Therefore, Lotus Bio-Technology Development's Cash Conversion Cycle (CCC) for the three months ended in Dec. 2017 was 0.00.


Lotus Bio-Technology Development Cash Conversion Cycle Historical Data

The historical data trend for Lotus Bio-Technology Development's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lotus Bio-Technology Development Cash Conversion Cycle Chart

Lotus Bio-Technology Development Annual Data
Trend Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17
Cash Conversion Cycle
Get a 7-Day Free Trial - - - - -

Lotus Bio-Technology Development Quarterly Data
Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Lotus Bio-Technology Development's Cash Conversion Cycle

For the Agricultural Inputs subindustry, Lotus Bio-Technology Development's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lotus Bio-Technology Development's Cash Conversion Cycle Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Lotus Bio-Technology Development's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Lotus Bio-Technology Development's Cash Conversion Cycle falls into.



Lotus Bio-Technology Development Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Lotus Bio-Technology Development's Cash Conversion Cycle for the fiscal year that ended in Mar. 2017 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=+-
=0.00

Lotus Bio-Technology Development's Cash Conversion Cycle for the quarter that ended in Dec. 2017 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=+-
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lotus Bio-Technology Development  (OTCPK:LBTD) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Lotus Bio-Technology Development Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Lotus Bio-Technology Development's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Lotus Bio-Technology Development (Lotus Bio-Technology Development) Business Description

Traded in Other Exchanges
N/A
Address
108 2559 Parkview Lane, Port Coquitlam, BC, CAN, V3C6M1
Lotus Bio-Technology Development Corp is a biotechnology development company. It focuses on specializing in the refining of organic materials and the production of natural consumer-related products. It is exploring opportunities in the organic growth and farming sector in China and provides local customers the real organic food products with affordable prices and guarantees that all of them will be produced in an environmentally responsible way and not be grown with pesticides, synthetic fertilizers, antibiotics, growth hormones, or other dangerous chemicals. All the operation is primarily functioned through the region of China.
Executives
Zoltan Nagy other: FX President/CEO 1361 PELTIER DR., POINT ROBERTS WA 98281